COVID-19 与癌症：我们真的了解我们自以为了解的吗？
COVID-19 and cancer: do we really know what we think we know?
机构信息
Department of Oncology, Queen's University, Kingston, ON, Canada.
Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Queen's University, Kingston, ON, Canada.
出版信息
Nat Rev Clin Oncol. 2020 Jul;17(7):386-388. doi: 10.1038/s41571-020-0394-y.
Abstract
Early published data on COVID-19 in patients with cancer are being referenced in clinical guidelines, despite methodological flaws that limit the quality of much of this evidence. In the next phase of research in this area, we argue that the quality of observational evidence should be prioritized over speed of publication.
摘要
早期发表的关于癌症患者 COVID-19 的数据被临床指南引用，尽管这些数据存在方法学缺陷，限制了大部分证据的质量。在该领域的下一阶段研究中，我们认为观察性证据的质量应该优先于发表速度。
相似文献
1
COVID-19 and cancer: do we really know what we think we know?
Nat Rev Clin Oncol. 2020 Jul;17(7):386-388. doi: 10.1038/s41571-020-0394-y.
2
Challenges Faced by Medical Journals During the COVID-19 Pandemic.
J Clin Oncol. 2020 Jul 1;38(19):2206-2207. doi: 10.1200/JCO.20.00858. Epub 2020 Apr 8.
3
COVID-19 in a Kidney Transplant Patient.
Eur Urol. 2020 Jun;77(6):769-770. doi: 10.1016/j.eururo.2020.03.036. Epub 2020 Apr 6.
4
COVID-19-related Mortality During the First 60 Days After Kidney Transplantation.
Eur Urol. 2020 Oct;78(4):641-643. doi: 10.1016/j.eururo.2020.06.036. Epub 2020 Jun 19.
5
[COVID-19- what have we learned and where are we heading?].
Laeknabladid. 2020 Oct;106(10):449. doi: 10.17992/lbl.2020.10.598.
6
Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
JAMA Oncol. 2020 Oct 1;6(10):1529-1530. doi: 10.1001/jamaoncol.2020.2367.
7
Optimal Management of Acute Lymphoblastic Leukemia (ALL) in Adult Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic.
Gulf J Oncolog. 2020 May;1(33):7-18.
8
Triage of patients with COVID-19.
Br J Gen Pract. 2020 Jun 25;70(696):327. doi: 10.3399/bjgp20X710825. Print 2020 Jul.
9
Hematopoietic stem cell transplantation dilemma during the COVID-19 era.
Future Oncol. 2020 Aug;16(22):1569-1573. doi: 10.2217/fon-2020-0414. Epub 2020 May 27.
10
The Early Days: The Postkidney Transplant Recipients' COVID-19 Journey.
Clin J Am Soc Nephrol. 2020 Sep 7;15(9):1221-1223. doi: 10.2215/CJN.08780620. Epub 2020 Jul 29.
引用本文的文献
1
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry.
Ther Adv Med Oncol. 2024 Jan 18;16:17588359231225028. doi: 10.1177/17588359231225028. eCollection 2024.
2
Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy.
Curr Oncol. 2022 May 6;29(5):3364-3374. doi: 10.3390/curroncol29050273.
3
Global cancer research in the era of COVID-19: a bibliometric analysis.
Ecancermedicalscience. 2021 Jul 7;15:1264. doi: 10.3332/ecancer.2021.1264. eCollection 2021.
4
The risks associated with the widespread use of telemedicine in oncology: Four cases and review of the literature.
Cancer Rep (Hoboken). 2022 Jul;5(7):e1531. doi: 10.1002/cnr2.1531. Epub 2021 Aug 18.
5
Seroprevalence of SARS-CoV-2-Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy.
J Clin Med. 2021 Apr 4;10(7):1503. doi: 10.3390/jcm10071503.
6
A Systematic Review and Meta-Analysis of Cancer Patients Affected by a Novel Coronavirus.
JNCI Cancer Spectr. 2021 Feb 24;5(2):pkaa102. doi: 10.1093/jncics/pkaa102. eCollection 2021 Apr.
7
Cumulative COVID-19 incidence, mortality and prognosis in cancer survivors: A population-based study in Reggio Emilia, Northern Italy.
Int J Cancer. 2021 Apr 16;149(4):820-6. doi: 10.1002/ijc.33601.
8
Narrative review of lung cancer treatment at the time of COVID-19 pandemia: pitfall and issues.
Transl Lung Cancer Res. 2021 Jan;10(1):475-482. doi: 10.21037/tlcr-20-640.
9
Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection.
Cancers (Basel). 2020 Nov 16;12(11):3383. doi: 10.3390/cancers12113383.
10
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study.
Ther Adv Med Oncol. 2020 Oct 23;12:1758835920971147. doi: 10.1177/1758835920971147. eCollection 2020.
本文引用的文献
1
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study.
JAMA Oncol. 2020 Jul 1;6(7):1028-1037. doi: 10.1001/jamaoncol.2020.1271.
2
Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients.
Ann Oncol. 2020 Aug;31(8):991-1000. doi: 10.1016/j.annonc.2020.04.008. Epub 2020 Apr 26.
3
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak.
Cancer Discov. 2020 Jun;10(6):783-791. doi: 10.1158/2159-8290.CD-20-0422. Epub 2020 Apr 28.
4
Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City.
Ann Oncol. 2020 Aug;31(8):1088-1089. doi: 10.1016/j.annonc.2020.04.006. Epub 2020 Apr 21.
Zotero 插件